Drugs / Xiang-Sha-Liu-Jun formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04668222 | Apr 2021 → Nov 2022 | COVID-19 | The University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiang-Sha-Liu-Jun formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04668222 ↗ |